Astrazeneca Plc 4375 Bond Operating Margin

046353AU2   89.74  1.28  1.45%   
ASTRAZENECA PLC 4375 fundamentals help investors to digest information that contributes to ASTRAZENECA's financial success or failures. It also enables traders to predict the movement of ASTRAZENECA Bond. The fundamental analysis module provides a way to measure ASTRAZENECA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ASTRAZENECA bond.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

ASTRAZENECA PLC 4375 Corporate Bond Operating Margin Analysis

ASTRAZENECA's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, ASTRAZENECA PLC 4375 has an Operating Margin of 0.0%. This indicator is about the same for the Manufacturing average (which is currently at 0.0) sector and about the same as Industrial (which currently averages 0.0) industry. This indicator is about the same for all United States bonds average (which is currently at 0.0).

ASTRAZENECA Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ASTRAZENECA's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the bonds which would be a good addition to a portfolio. Peer analysis of ASTRAZENECA could also be used in its relative valuation, which is a method of valuing ASTRAZENECA by comparing valuation metrics of similar companies.
ASTRAZENECA PLC cannot be rated in Operating Margin category at this point.

About ASTRAZENECA Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ASTRAZENECA PLC 4375's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ASTRAZENECA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ASTRAZENECA PLC 4375 based on its fundamental data. In general, a quantitative approach, as applied to this corporate bond, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in ASTRAZENECA Bond

ASTRAZENECA financial ratios help investors to determine whether ASTRAZENECA Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ASTRAZENECA with respect to the benefits of owning ASTRAZENECA security.